David H. Koch Institute for Integrative Cancer Research
For more than 30 years after Richard Nixon’s 1970s declaration of “war on cancer,” the MIT Center for Cancer Research (CCR) played a prominent role in defining the critical cellular processes that are affected during cancer development. Now, the CCR has itself been redefined, emerging today as the David H. Koch Institute for Integrative Cancer Research.
The Koch Institute, like its predecessor, grows out of MIT’s proven strengths in molecular biology, genetics, cell biology, and immunology.
But what makes this new enterprise so unique is the integral role that MIT’s engineering powerhouse will play.
The new Institute remains committed to carrying forward one of MIT’s proudest traditions: the transfer of basic science out of the laboratory and into the world, where innovation has its real impacts.
The Koch Institute for Integrative Cancer Research is an institutional priority now. You can read more about it, and about what you can do to support it—at any level—in the “Emerging projects” section of this Web site.
| 
